Serum levels of insulin-like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 428, 1999, Pages 185-191

  Burren, C P ^a   Wanek, D ^a   Mohan, S ^b   Cohen, P ^c   Guevara Aguirre, J ^d   Rosenfeld, R G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Department of Pediatrics   (Ecuador)

Author keywords

Growth hormone; Growth hormone insensitivity; Insulin like growth factor binding protein; Insulin like growth factor I

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5;

BODY HEIGHT; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; ECUADOR; FEMALE; HORMONE DETERMINATION; HORMONE RECEPTOR INTERACTION; HORMONE RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; ECUADOR; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; RADIOIMMUNOASSAY; RECEPTORS, SOMATOTROPIN; REFERENCE VALUES; SYNDROME;

EID: 0033014661     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Spagnoli A, Rosenfeld RG. The mechanisms by which growth hormone brings about growth. Pediatr Clin North Am 1996;25:615-31
2. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34
3. Gucev ZS, Oh Y, Kelley KM, Labarta JI, Vorwerk P, Rosenfeld RG. Evidence of insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells. Endocrinology 1997;138:1464-70
4. Spagnoli A, Rosenfeld RG. Insulin-like growth factor binding proteins. Curr Opin Endocrinol Diabetes 1997;4:1-9
5. Baxter RC, Dai J. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 1994;134:848-52
6. Baxter RC. Characterization of the acid-labile subunit of the growth hormone dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1988;67:265-72
7. Daughaday WH, Hall K, Raben MS, Salmon JWD, van den Brande JL, van Wyk JJ. Somatomedin: a proposed designation for the "sulfation factor". Nature 1972;235:107
8. Green H, Morikawa M, Nixon.T. A dual effector theory of growth hormone action. Differentiation 1985;29:195-8
9. Chin E, Zhou J, Dai J, Baxter RC, Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary complex. Endocrinology 1994;134:2498-504
10. Dai J, Scott CD, Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 1994;135:1066-72
11. Skottner A, Clark RG, Fryklund L, Robinson ICAF. Growth responses of a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 1989;124:2519-26
12. Lewitt MS, Saunders H, Phuyal JL, Baxter RC. Complex formation by insulin-like growth factor binding protein-3 and human acid-labile subunit in growth hormone deficient rats. Endocrinology 1994;134:2404-9
13. Gargosky SE, Tapanainen P, Rosenfeld RG. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodaIton IGF-binding protein -3 complex in GH-deficient rats. Endocrinology 1994;134:2267-76
14. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 1996;137:1913-20
15. Butler AA, Gallaher BW, Ambler GR, Gluckman PD, Breier BH. IGF-I and IGF-binding protein-3 in plasma of GH-deficient rats. J Endocrinol 1996;150:67-76
16. Blum WF, Ranke MB, Kietzman K, Gauggel E, Zeisel HJ, Bierich J. A specific radio-immunoassay for the growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-8
17. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab 1996;81:2111-16
18. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone -a new inborn error of metabolism? Isr J Med Sci 1966;2: 152-5
19. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage M, et al. Classification of growth hormone insensitivity syndrome. J Pediatr 1993;122:241
20. Rosenbloom AL, Rosenfeld RG, Guevara-Aguirre J. Growth hormone insensitivity. Pediatr Clin North Am 1997;44:423-42
21. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-7
22. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-90
23. Meacham LR, Brown MR, Murphy RL, Keret R, Silbergeld A, Laron Z, et al. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. J Clin Endocrinol Metab 1993;77:1379-83
24. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Helmiss R, Keret R, et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989;86:8083-7
25. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Fielder PJ. The little women of Loja - growth hormone receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 1990;323:1367-74
26. Guevara-Aguirre J, Rosenbloom AL, Vaccarello MA, Fielder PJ, de la Vega A, Diamond FBJ, et al. Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics. Acta Paediatr Scand Suppl 1991;377:96-103
27. Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RG, Francke U. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Hum Mutat 1992;1:24-32
28. Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond FBJ, et al. A randomized double-blind placebo-controlled trial of safety and efficacy of recombinant insulin-like growth factor in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 1995;80:1393-8